scispace - formally typeset
S

Sougata Roy Chowdhury

Researcher at University of Calcutta

Publications -  15
Citations -  877

Sougata Roy Chowdhury is an academic researcher from University of Calcutta. The author has contributed to research in topics: Fucose & Bacillus megaterium. The author has an hindex of 11, co-authored 15 publications receiving 658 citations. Previous affiliations of Sougata Roy Chowdhury include Indian Institute of Technology Kharagpur.

Papers
More filters
Journal ArticleDOI

Enhancement of tensile strength of lignocellulosic jute fibers by alkali-steam treatment.

TL;DR: The results from this investigation indicate that a 30 min dipping of the fibers in 0.5% alkali solution followed by 30 min alkali-steam treatment leads to an increase in the tensile strength of up to 65%, which appears to be due to fiber separation and removal of non-cellulosic materials, which, in turn, resulted in an increased crystallinity.
Journal ArticleDOI

Electrospun chitosan/polycaprolactone-hyaluronic acid bilayered scaffold for potential wound healing applications

TL;DR: Enhanced swelling, degradation, hydrophilicity and water vapour transmission rate were found for the bilayered scaffold compared to that of the PCL and CS-PCL scaffolds.
Journal ArticleDOI

Exosomes Produced by Mesenchymal Stem Cells Drive Differentiation of Myeloid Cells into Immunosuppressive M2-Polarized Macrophages in Breast Cancer.

TL;DR: It is demonstrated that exosomes secreted by human and mouse tumor-educated mesenchymal stem cells drive accelerated breast cancer progression by inducing differentiation of monocytic myeloid-derived suppressor cells into highly immunosuppressive M2-polarized macrophages at tumor beds.
Journal ArticleDOI

CXCL13–CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis

TL;DR: The EMT-inducing potential of CXCL13 is shown as well as the prognostic value of C XCL13–CXCR5 co-expression in primary BC is demonstrated, suggesting that CxCL13-CX CR5–RANKL–Src axis may present a therapeutic target in LNM positive BC patients.